Effect of recombinant insulin-like growth factor I on anterior pituitary function in healthy volunteers.
Trainer
P J
PJ
Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London, UK.
Holly
J
J
Medbak
S
S
Besser
G M
GM
D001682:Biological Availability; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D002352:Carrier Proteins / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007003:Hypoglycemia / Q000139:chemically induced; D007279:Injections, Subcutaneous; D007328:Insulin / Q000097:blood; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D007335:Insulin-Like Growth Factor II / Q000032:analysis; D008297:Male; D010903:Pituitary Gland, Anterior / Q000187:drug effects* / Q000502:physiology*; D010907:Pituitary Hormones / Q000097:blood
D001786:Blood Glucose; D002096:C-Peptide; D002352:Carrier Proteins; D007328:Insulin; D018969:Insulin-Like Growth Factor Binding Proteins; D010907:Pituitary Hormones; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D006854:Hydrocortisone